ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
98,293.49
0.19%
S&P 500
5,942.47
1.26%
Dow Jones
42,732.13
0.80%
US Dollar vs Yen
157.205
0.01%
Brent Oil
76.495
0.00%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ

  6. Caribou Biosciences Inc (CRBU) 銘柄情報

Caribou Biosciences Inc

Caribou Biosciences Inc (CRBU)

Amd Commo Exagr
1.72
0.04
(2.38%)
終了 1月5日 6:00AM
15分遅延
1.68
-0.04
(-2.33%)
取引時間後: 8:56AM
15分遅延

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

主要統計と詳細

通貨
1.68
買値
1.68
売値
6.00
出来高
782,282
1.65 日の範囲 1.73
1.50 52 週間の範囲 8.33
時価総額
152.129M
前日終値
1.68
始値
1.68
時刻
100
@
1.68
(formt)
最終取引時間
財務取引量
US$ 1,323,065
VWAP
1.6913
平均取引量 (3 か月)
1,476,373
発行済株式数
90,552,687
配当利回り
-
PER
-1.51
1 株当たり利益 (EPS)
-1.13
歳入
34.48M
純利益
-102.07M

Caribou Biosciences Inc について

Caribou Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. Caribou Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies.

セクター
Biological Pds,ex Diagnstics
業界
Biological Pds,ex Diagnstics
ウェブサイト
www.cariboubio.com
本社
Dover, Delaware, USA
設立
-
Caribou Biosciences Inc is listed in the Biological Pds,ex Diagnstics sector of the ナスダック市場 with ticker CRBU. The last closing price for Caribou Biosciences was US$1.68. Over the last year, Caribou Biosciences shares have traded in a share price range of US$ 1.50 to US$ 8.33.

Caribou Biosciences currently has 90,552,687 shares in issue. The market capitalisation of Caribou Biosciences is US$152.13 million. Caribou Biosciences has a price to earnings ratio (PE ratio) of -1.51.

CRBU 最新ニュース

その他のニュース

Class Action Filed Against Caribou Biosciences, Inc. (CRBU) Seeking Recovery for Investors - Contact The Gross Law Firm

Class Action Filed Against Caribou Biosciences, Inc. (CRBU) Seeking Recovery for Investors - Contact The Gross Law Firm PR Newswire NEW YORK, Jan. 2, 2025 NEW YORK, Jan. 2, 2025 /PRNewswire/...

2025年1月3日
PR Newswire (US)

Form 8-K - Current report

2025年1月2日
Edgar (US Regulatory)

Caribou Biosciences Appoints Sri Ryali as Chief Financial Officer

BERKELEY, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the...

2025年1月2日
GlobeNewswire Inc.

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

2024年12月7日
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

2024年11月23日
Edgar (US Regulatory)

Caribou Biosciences to Participate in Upcoming Investor Conferences

BERKELEY, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel...

2024年11月21日
GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

2024年11月15日
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

2024年11月7日
Edgar (US Regulatory)

Form 8-K - Current report

2024年11月7日
Edgar (US Regulatory)

Caribou Biosciences Reports Third Quarter 2024 Financial Results and  Provides Business Update

-- Advancing four clinical-stage programs for hematologic malignancies and autoimmune diseases; multiple clinical data reports planned for 2025 -- -- Enrolling patients with LBCL (2L and after...

2024年11月7日
GlobeNewswire Inc.
期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.01-0.5917159763311.691.7751.5415462551.63182602CS
4-0.33-16.41791044782.012.261.5414176351.83467268CS
12-0.12-6.666666666671.82.99951.5414763732.09443516CS
260.0851.62.99951.513794432.10534789CS
52-3.84-69.56521739135.528.331.516803353.29332505CS
156-13.46-88.903566710715.1415.851.513207845.26571406CS
260-15.97-90.481586402317.6532.6451.512348236.43314724CS

CRBU - Frequently Asked Questions (FAQ)

What is the current Caribou Biosciences share price?
The current share price of Caribou Biosciences is US$ 1.68
How many Caribou Biosciences shares are in issue?
Caribou Biosciences has 90,552,687 shares in issue
What is the market cap of Caribou Biosciences?
The market capitalisation of Caribou Biosciences is USD 152.13M
What is the 1 year trading range for Caribou Biosciences share price?
Caribou Biosciences has traded in the range of US$ 1.50 to US$ 8.33 during the past year
What is the PE ratio of Caribou Biosciences?
The price to earnings ratio of Caribou Biosciences is -1.51
What is the cash to sales ratio of Caribou Biosciences?
The cash to sales ratio of Caribou Biosciences is 4.47
What is the reporting currency for Caribou Biosciences?
Caribou Biosciences reports financial results in USD
What is the latest annual turnover for Caribou Biosciences?
The latest annual turnover of Caribou Biosciences is USD 34.48M
What is the latest annual profit for Caribou Biosciences?
The latest annual profit of Caribou Biosciences is USD -102.07M
What is the registered address of Caribou Biosciences?
The registered address for Caribou Biosciences is 3500 S DUPONT HWY, KENT, DOVER, DELAWARE, 19901
What is the Caribou Biosciences website address?
The website address for Caribou Biosciences is www.cariboubio.com
Which industry sector does Caribou Biosciences operate in?
Caribou Biosciences operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
FCUVFocus Universal Inc
US$ 0.9499
(174.93%)
260.93M
NITON2OFF Inc
US$ 2.6306
(145.85%)
358.28M
CRNCCerence Inc
US$ 19.33
(143.76%)
161.8M
KITTNauticus Robotics Inc
US$ 3.8249
(140.56%)
104.8M
ACONAclarion Inc
US$ 0.2984
(110.14%)
305.64M
HWHHWH International Inc
US$ 0.4621
(-28.80%)
7.43M
SMSTDefiance Daily Target 2x Short MSTR ETF
US$ 5.69
(-26.30%)
24.77M
RAINRain Enhancement Technologies Holdco Inc
US$ 5.59
(-23.42%)
161.15k
PTLEPTL Ltd
US$ 9.35
(-23.30%)
1.04M
NXUNXU Inc
US$ 0.725868
(-22.78%)
7.59M
NITON2OFF Inc
US$ 2.6306
(145.85%)
350.92M
TGLTreasure Global Inc
US$ 0.382
(101.58%)
330.82M
ACONAclarion Inc
US$ 0.2984
(110.14%)
305.59M
FCUVFocus Universal Inc
US$ 0.9499
(174.93%)
259.78M
NVDANVIDIA Corporation
US$ 144.47
(4.45%)
222.72M

CRBU Discussion

投稿を表示

最近閲覧した銘柄

NASDAQ
CRBU
Caribou Biosciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有